Long-term outcomes and prognostic factors after surgery alone for brain arteriovenous malformation

OBJECTIVES: There is a paucity of data regarding the long-term hemorrhage/progression outcomes of brain arteriovenous malformation (BAVM). The purpose of this study was to examine the outcomes of surgical treatment alone over a long follow-up period. MATERIALS AND METHODS: All patients (n = 356) har...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhao-Ying Zhu, Wei Zhang, Li-Chuan Gao, Gui-Jun Zhang, Jing Chen
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Brain Circulation
Subjects:
Online Access:https://journals.lww.com/10.4103/bc.bc_95_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850151892389199872
author Zhao-Ying Zhu
Wei Zhang
Li-Chuan Gao
Gui-Jun Zhang
Jing Chen
author_facet Zhao-Ying Zhu
Wei Zhang
Li-Chuan Gao
Gui-Jun Zhang
Jing Chen
author_sort Zhao-Ying Zhu
collection DOAJ
description OBJECTIVES: There is a paucity of data regarding the long-term hemorrhage/progression outcomes of brain arteriovenous malformation (BAVM). The purpose of this study was to examine the outcomes of surgical treatment alone over a long follow-up period. MATERIALS AND METHODS: All patients (n = 356) harboring Grade I–III BAVMs who had been surgically treated alone between January 2010 and December 2019 were included. Univariate analysis and multivariate analysis with proportional hazard models were implemented to identify the predictors of hemorrhage-free survival (HFS) (n = 356) and progression-free survival (PFS) (n = 334). RESULTS: Of the 356 BAVM patients, 233 were male and 123 were female (male-to-female ratio of 1.89:1). Rehemorrhage was observed in 22 (6.2%) patients. The overall HFS rates at 5, 10, and 15 years in the entire cohort were 96.0%, 92.4%, and 91.1%, respectively. A 1 cm3 increase in lesion volume (hazard ratio [HR] = 1.049, 95% confidence interval [CI] = 1.013–1.085; P = 0.007) was a significant adverse factor for HFS. The probabilities of PFS at 5, 10, and 15 years were 94.9%, 90.6%, and 85.5%, respectively. With respect to clinical predictors of PFS, only male sex (HR = 3.146, 95% CI = 1.088–9.098; P = 0.034) was a significant predictor of PFS after surgical treatment in the univariate analysis. CONCLUSIONS: For the majority of patients, surgery remains the first-line treatment for BAVMs. Our study included a significant subset of patients who were successfully managed by surgery alone.
format Article
id doaj-art-8a771e548a46447c896faeab0f8efc46
institution OA Journals
issn 2455-4626
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Brain Circulation
spelling doaj-art-8a771e548a46447c896faeab0f8efc462025-08-20T02:26:06ZengWolters Kluwer Medknow PublicationsBrain Circulation2455-46262025-01-01111576310.4103/bc.bc_95_24Long-term outcomes and prognostic factors after surgery alone for brain arteriovenous malformationZhao-Ying ZhuWei ZhangLi-Chuan GaoGui-Jun ZhangJing ChenOBJECTIVES: There is a paucity of data regarding the long-term hemorrhage/progression outcomes of brain arteriovenous malformation (BAVM). The purpose of this study was to examine the outcomes of surgical treatment alone over a long follow-up period. MATERIALS AND METHODS: All patients (n = 356) harboring Grade I–III BAVMs who had been surgically treated alone between January 2010 and December 2019 were included. Univariate analysis and multivariate analysis with proportional hazard models were implemented to identify the predictors of hemorrhage-free survival (HFS) (n = 356) and progression-free survival (PFS) (n = 334). RESULTS: Of the 356 BAVM patients, 233 were male and 123 were female (male-to-female ratio of 1.89:1). Rehemorrhage was observed in 22 (6.2%) patients. The overall HFS rates at 5, 10, and 15 years in the entire cohort were 96.0%, 92.4%, and 91.1%, respectively. A 1 cm3 increase in lesion volume (hazard ratio [HR] = 1.049, 95% confidence interval [CI] = 1.013–1.085; P = 0.007) was a significant adverse factor for HFS. The probabilities of PFS at 5, 10, and 15 years were 94.9%, 90.6%, and 85.5%, respectively. With respect to clinical predictors of PFS, only male sex (HR = 3.146, 95% CI = 1.088–9.098; P = 0.034) was a significant predictor of PFS after surgical treatment in the univariate analysis. CONCLUSIONS: For the majority of patients, surgery remains the first-line treatment for BAVMs. Our study included a significant subset of patients who were successfully managed by surgery alone.https://journals.lww.com/10.4103/bc.bc_95_24brain arteriovenous malformationhemorrhage-free survivalprogression-free survivalsurgery alone
spellingShingle Zhao-Ying Zhu
Wei Zhang
Li-Chuan Gao
Gui-Jun Zhang
Jing Chen
Long-term outcomes and prognostic factors after surgery alone for brain arteriovenous malformation
Brain Circulation
brain arteriovenous malformation
hemorrhage-free survival
progression-free survival
surgery alone
title Long-term outcomes and prognostic factors after surgery alone for brain arteriovenous malformation
title_full Long-term outcomes and prognostic factors after surgery alone for brain arteriovenous malformation
title_fullStr Long-term outcomes and prognostic factors after surgery alone for brain arteriovenous malformation
title_full_unstemmed Long-term outcomes and prognostic factors after surgery alone for brain arteriovenous malformation
title_short Long-term outcomes and prognostic factors after surgery alone for brain arteriovenous malformation
title_sort long term outcomes and prognostic factors after surgery alone for brain arteriovenous malformation
topic brain arteriovenous malformation
hemorrhage-free survival
progression-free survival
surgery alone
url https://journals.lww.com/10.4103/bc.bc_95_24
work_keys_str_mv AT zhaoyingzhu longtermoutcomesandprognosticfactorsaftersurgeryaloneforbrainarteriovenousmalformation
AT weizhang longtermoutcomesandprognosticfactorsaftersurgeryaloneforbrainarteriovenousmalformation
AT lichuangao longtermoutcomesandprognosticfactorsaftersurgeryaloneforbrainarteriovenousmalformation
AT guijunzhang longtermoutcomesandprognosticfactorsaftersurgeryaloneforbrainarteriovenousmalformation
AT jingchen longtermoutcomesandprognosticfactorsaftersurgeryaloneforbrainarteriovenousmalformation